These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3510879)

  • 1. Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins.
    Kung HF; Smith MR; Bekesi E; Manne V; Stacey DW
    Exp Cell Res; 1986 Feb; 162(2):363-71. PubMed ID: 3510879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the protein.
    Lacal JC; Aaronson SA
    Mol Cell Biol; 1986 Apr; 6(4):1002-9. PubMed ID: 2431273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes.
    Montano X; Jimenez A
    Cell Growth Differ; 1995 May; 6(5):597-605. PubMed ID: 7647040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of yeast adenylate cyclase by antibodies to ras p21.
    Gibbs JB; Marsico-Ahern JD; Scolnick EM; Sigal IS
    Biochem J; 1988 May; 252(1):289-92. PubMed ID: 2458712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.
    Furth ME; Davis LJ; Fleurdelys B; Scolnick EM
    J Virol; 1982 Jul; 43(1):294-304. PubMed ID: 6287003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
    Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
    Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange.
    Hattori S; Clanton DJ; Satoh T; Nakamura S; Kaziro Y; Kawakita M; Shih TY
    Mol Cell Biol; 1987 May; 7(5):1999-2002. PubMed ID: 2439901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional polyacrylamide gel electrophoresis analysis of phosphorylated, membrane-localized ras p21 proteins.
    Polonis VR; Anderson GR; Doyle D
    Arch Biochem Biophys; 1987 May; 254(2):541-6. PubMed ID: 3555345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG; Sinn E; Carney WP
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of ras GTPase activity by an anti-ras monoclonal antibody.
    Agellon S; Stone JC
    Mol Carcinog; 1996 Jul; 16(3):132-8. PubMed ID: 8688148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical localization in normal and transformed human cells in tissue culture using a monoclonal antibody to the src protein of the Harvey strain of murine sarcoma virus.
    Willingham MC; Banks-Schlegel SP; Pastan IH
    Exp Cell Res; 1983 Nov; 149(1):141-9. PubMed ID: 6357812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of anti-RAS p21 monoclonal antibodies.
    Hamer PJ; Trimpe KL; Pullano T; Ng S; LaVecchio JA; Petit DA; DeLellis R; Wolfe H; Carney WP
    Hybridoma; 1990 Dec; 9(6):573-87. PubMed ID: 2076896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of effector residues and a neutralizing epitope of Ha-ras-encoded p21.
    Sigal IS; Gibbs JB; D'Alonzo JS; Scolnick EM
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4725-9. PubMed ID: 2425352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites.
    Werge TM; Bradbury A; Di Luzio A; Cattaneo A
    Oncogene; 1992 May; 7(5):1033-5. PubMed ID: 1570149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different levels of v-Ha-ras p21 expression in primary keratinocytes transformed with Harvey sarcoma virus correlate with benign versus malignant behavior.
    Brissette JL; Missero C; Yuspa SH; Dotto GP
    Mol Carcinog; 1993; 7(1):21-5. PubMed ID: 8435106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between H-ras p21TLeu61 protein content and tumorigenicity of NIH3T3 cells.
    Bizub D; Blair D; Alvord G; Skalka AM
    Oncogene; 1988 Oct; 3(4):443-8. PubMed ID: 3078952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Stacey DW; Kung HF
    Nature; 1984 Aug 9-15; 310(5977):508-11. PubMed ID: 6611509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP.
    Radosevich JA; Combs SG; Ma Y; Lee I; Gould VE; Thor A; Schlom J; Carney WP; Rosen ST
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):337-44. PubMed ID: 2565631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.